Grace Therapeutics (GRCE) Net Margin (2012 - 2026)
Grace Therapeutics (GRCE) posted Net Margin of -11198.58% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 9550.54 percentage points from -1648.04% a year earlier and down 10344.96 percentage points from the prior quarter.
Grace Therapeutics (GRCE) Net Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Grace Therapeutics was -3245.75%, down 1766.12 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -1137.66%, up 176.62 percentage points from FY2025.
- Annual Net Margin shows a five-year change of +8902.13 percentage points (FY2021 to FY2026).
- In prior fiscal years, Grace Therapeutics' Net Margin was -1314.29% in FY2025 (+154.63 pp) and -1468.91% in FY2024.
- The fiscal Q1 2027 figure stands as the lowest quarterly Net Margin since fiscal Q3 2016.
- On a year-over-year basis, Net Margin increased in two of the last five quarters, with an average year-over-year change of -1603.63 percentage points.
- According to Business Quant data, Net Margin for the three prior fiscal quarters was -853.62% (Q4 2026), -1345.93% (Q3 2026) and -545.35% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 19.55% |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | -1,383.77% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,198.58% |
| Mar 31, 2026 | -853.62% |
| Dec 31, 2025 | -1,345.93% |
| Sep 30, 2025 | -545.35% |
| Jun 30, 2025 | -1,648.04% |
| Mar 31, 2025 | 345.65% |
| Dec 31, 2024 | -3,271.65% |
| Sep 30, 2024 | -1,885.71% |
| Jun 30, 2024 | -1,113.62% |
| Mar 31, 2021 | -4,909.57% |
| Dec 31, 2020 | -3,975.31% |
| Mar 31, 2018 | -0.55% |
| Nov 30, 2016 | -143.86% |
| Aug 31, 2016 | -63,790.74% |
| May 31, 2016 | -109,210.53% |
| Nov 30, 2015 | -43,180.92% |
| Aug 31, 2015 | -17,725.46% |
| May 31, 2015 | -18,737.80% |
| Feb 28, 2015 | -1,298.31% |
| Nov 30, 2014 | 10,451.41% |
Grace Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();